Table 3B.
Treatment Group | VEGF | Placebo | P value |
---|---|---|---|
Changes in Electrophysiologic Variables (Median, Interquartile Range) | |||
Tibial Amplitude | |||
Untreated Leg | 0.0 (−0.3, 0.1) | −0.1 (−1.3, 0.0) | 0.33 |
Treated Leg | 0.0 (−0.2, 0.1) | −0.4 (−2.3, 0.0) | 0.27 |
Peroneal Amplitude | |||
Untreated Leg | 0.0 (−0.2, 0.1) | 0.0 (−0.3, 0.6) | 0.88 |
Treated Leg | 0.0 (−0.3, 0.0) | 0.0 (−0.1, 0.9) | 0.12 |
Amplitude Sum | |||
Untreated Leg | 0.0 (−0.3, 0.1) | 0.0 (−3.0, 0.4) | 0.80 |
Treated Leg | −0.1 (−0.4, 0.0) | 0.0 (−1.0, 0.1) | 0.64 |
Sural Amplitude | |||
Untreated Leg | 0.0 (0.0, 0.0) | 0.0 (−0.5, 0.0) | 0.44 |
Treated Leg | 0.0 (0.0, 0.0) | 0.0 (−0.8, 0.0) | 0.36 |
Changes in JND Measurements (Mean, Standard Error) | |||
Cold | |||
Untreated Leg | −0.15 (1.11) | −3.14 (3.98) | 0.31 |
Treated Leg | −0.68 (1.21) | 2.01 (4.65) | 0.30 |
Vibration | |||
Untreated Leg | 0.84 (0.81) | −1.66 (1.31) | 0.15 |
Treated Leg | 0.07 (0.88) | −0.43 (0.51) | 0.69 |